But Vyvanse has already been on the market since 2007 as a daily treatment for attention deficit hyperactivity disorder (ADHD) in children and adults. So how does this drug act on two seemingly distinct conditions? Although amphetamines have long been ...
from Meta Search Alerts http://ift.tt/1yvLbD9
via IFTTT
from Meta Search Alerts http://ift.tt/1yvLbD9
via IFTTT
No comments:
Post a Comment